Elicio Therapeutics drops 5%, prices $15M registered direct offering
Seeking Alpha ·
Elicio Therapeutics ( ELTX ) priced a $15M registered direct offering led by two new fundamental institutional investors, with participation from an existing large shareholder. The clinical-stage biotechnology company agreed to sell about 4.38M shares of common stock in the offering.
DYAX Investor Sentiment
Bullish (Long) 40% · Bearish (Short) 60%
349 participants
Related News
- Europe markets in green as risk appetite lifts
- Mitsubishi Electric wholly acquires space-tech firm Infostellar
- Google loses appeal over $4.7B EU Android antitrust fine
- German drone startup Quantum Systems secures $1.2B at $8B valuation
- Taiwan detains two Super Micro employees in alleged Nvidia AI server export probe - report
- EU top court dismisses Google fight against record €4.1 billion EU antitrust fine